You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in

NHL: From Emerging Treatment Strategies to Routine Practice

The programs on this page raise awareness of emergent therapies for NHL, the biological and clinical rationale for these treatments and the supporting evidence, and provide practical guidance on their optimal application in real-world practice.

Supported by an independent educational grant from

CME Activities

See All

Polling Question

Related Resources

See All

Steering Committee

Gilles Salles, MD, PhD

Gilles Salles, MD, PhD

Steering Committee Chair

Professor of Medicine
Chief of the Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Jeremy S. Abramson, MD

Jeremy S. Abramson, MD

Associate Professor of Medicine
Harvard Medical School
Director, Center for Lymphoma
Massachusetts General Hospital
Boston, Massachusetts, United States

Koji Izutsu, MD, PhD

Koji Izutsu, MD, PhD

Chief, Department of Hematology
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan

Marie Josie Kersten, MD, PhD

Marie José Kersten, MD, PhD

Department of Hematology location AMC LYMMCARE (Lymphoma and Myeloma Center Amsterdam)
Amsterdam, Netherlands

Marion Subklewe, MD

Marion Subklewe, MD

Professor for Cellular Immunotherapy
Associate Professor for Hematology
University Hospital of Munich
Munich, Bavaria, Germany

Umberto Vitolo, MD

Umberto Vitolo, MD

Hematology Consultant Candiolo Cancer Institute,Fondazione Piemontese per l'Oncologia-IRCCS
Candiolo (Torino), Italy